Sullivan, Patrick - Loretto Heights College

个人简介

Ph.D. Pharmaceutical Economics, University of Southern California School of Pharmacy, Department of Pharmaceutical Economics and Policy, 2001 M.A. Economics, University of Colorado, Denver, CO, 1993 Certificate Graduate Studies (European Economic Policy), Katholieke Universiteit Te Leuven, Leuven, Belgium, 1992 B.A. Politics, Certificate Saint Ignatius Institute (Great Books program) University of San Francisco, San Francisco, CA, 1990 Oxford University (Keble College, Center for Medieval and Renaissance Studies), Oxford, England, 1989

研究领域

Cost-effectiveness analysis Pharmacoeconomics Utility assessment and health-related quality of life (HRQL)

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Sullivan PW, Globe G, Ghushchyan VH, Campbell JD, Bender B, Magid DJ. Exploring asthma control cutoffs and economic outcomes using the Asthma Control Questionnaire. Ann Allergy Asthma Immunol. 2016 Sep;117(3):251-257.e2. doi: 10.1016/j.anai.2016.07.020. PMID:27613458 Sullivan PW, Ghushchyan VH, Campbell JD, Globe G, Bender B, Magid DJ. Measurement of utility in asthma: evidence indicating that generic instruments may miss clinically important changes. Qual Life Res. 2016 Jul 7. [Epub ahead of print] PMID:27387417 Sullivan PW, Ghushchyan VH, Campbell JD, Globe G, Bender B, Magid DJ.Measuring the cost of poor asthma control and exacerbations. J Asthma. 2016 Jun 10:1- Sullivan, PW, Campbell, JD, Ghushchyan, VH, Globe, G (2015). Outcomes before and after treatment escalation to Global Initiative for Asthma steps 4 and 5 in severe asthma. Annals of allergy, asthma & immunology. Jun;114(6):462-9. Sullivan, PW, Campbell, JD, Globe, G, Ghushchyan, VH, Bender, B, Schatz, M, Chon, Y, Woolley, JM, Magid, DJ (2015). Measuring the effect of asthma control on exacerbations and health resource use. Journal of Allergy& Clinical Immunology. Jun 12. pii: S0091-6749(15)00655-7. doi: 10.1016/j.jaci.2015.04.046. Sullivan, PW, Campbell, JD, Ghushchyan, VH, Globe, G, Lange, J, Woolley, JM (2015). Characterizing the severe asthma population in the United States: claims-based analysis of three treatment cohorts in the year prior to treatment escalation. The Journal of asthma. Sep;52(7):669-80. Slejko JF, Sullivan PW, Anderson HD, Ho PM, Nair KV, Campbell JD. (2014). Dynamic medication adherence modeling in primary prevention of cardiovascular disease: a markov microsimulation methods application. Value Health. (6):725-31. DOI: 10.1016/j.jval.2014.06.010. Epub 2014 Jul 28. http://www.ncbi.nlm.nih.gov/pubmed/25236996 Slejko, J. F., Ho, M., Anderson, H. D., Nair, K. V., Sullivan, P. W., & Campbell, J. D. (2014). Adherence to statins in primary prevention: yearly adherence changes and outcomes. Journal of Managed Care Pharmacy: JMCP, 20(1), 51–57. Sullivan, P. W., Slejko, J. F., Ghushchyan, V. H., Sucher, B., Globe, D. R., Lin, S.-L., & Globe, G. (2014). The relationship between asthma, asthma control and economic outcomes in the United States. The Journal of Asthma: Official Journal of the Association for the Care of Asthma, doi: 10.3109/02770903.2014.906607. Sullivan, P. W., Smith, K. L., Ghushchyan, V. H., Globe, D. R., Lin, S.-L., & Globe, G. (2013). Asthma in USA: its impact on health-related quality of life. The Journal of Asthma: Official Journal of the Association for the Care of Asthma, 50(8), 891–899. doi:10.3109/02770903.2013.813035 Sullivan, Patrick W., Slejko, Julia F., Ghushchyan, Vahram,H., Sucher, B, Globe, Denise R., Lin, Shao-Lee, and Globe, G. The relationship between asthma, asthma control and economic outcomes in the United States. The Journal of Asthma: Official Journal of the Association for the Care of Asthma, doi: 10.3109/02770903.2014.906607. Slejko, J. F., Ghushchyan, V. H., Sucher, B., Globe, D. R., Lin, S.-L., Globe, G., & Sullivan, P. W. (2013). Asthma control in the United States, 2008-2010: Indicators of poor asthma control. The Journal Of Allergy And Clinical Immunology. Sullivan, P.W., Ghushchyan, V., Bayliss, E. (2012). The impact of comorbidity burden on preference-based HRQL in the United States. Pharmacoeconomics, 30(5), 431–42. McQueen RB, Ellis SL, Campbell JD, Nair KV, Sullivan PW2. Cost-Effectiveness of Continuous Glucose Monitoring and Intensive Insulin Therapy for Type 1 Diabetes. Cost Effectiveness and Resource Allocation. 2011, 9:13. Padula WV, Sullivan PW2, Beyond migraines: how healthy are the 2012 presidential contenders? The Atlantic. August 3, 2011. http://www.theatlantic.com/politics/archive/2011/08/beyond-migraines-how-healthy-are-the-2012-presidential-contenders/242494/ Sullivan PW1. Are Utilities Bounded at 1.0? Implications for Statistical Analysis and Scale Development. Medical Decision Making. Mar 21 2011. Sullivan PW1, Slejko MF, Sculpher MJ, Ghushchyan V. Catalogue of EQ-5D Scores for the United Kingdom. Medical Decision Making. 2011 Dec; 31(6):800-804. Padula WV, Mishra MK, Makic MBF, Sullivan PW2. Improving the quality of pressure ulcer care with prevention: a cost-effectiveness analysis. Medical Care. 2011 Apr;49(4):385-392. Sullivan PW1, Ghushchyan V, Bayliss E. The impact of comorbidity burden on preference-based HRQL in the United States. Pharmacoeconomics. 2011. In Press. Sullivan PW1, Ghushchyan V, Slejko J, Belozeroff V, Globe D, Lin S. The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. Journal of Allergy and Clinical Immunology. 2011 Feb;127(2):363-369.